Rearrangements including deletions and translocations of TSLPR can be associated in the majority of B-ALL with activating mutations in the gene encoding the tyrosine kinase JAK2, which signals downstream of the TSLP receptor complex (133–135, 137). The gene discussed is CRLF2; the disease is precursor B-cell acute lymphoblastic leukemia.